Propanc Biopharma Inc
NASDAQ:PPCB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Propanc Biopharma Inc
NASDAQ:PPCB
|
AU |
|
D
|
Digital Turbine Inc
F:4MD
|
US |
|
F
|
Floor & Decor Holdings Inc
F:1FD
|
US |
|
P/F Bakkafrost
F:6BF
|
FO |
|
Digital Turbine Inc
NASDAQ:APPS
|
US |
Intrinsic Value
Is PPCB undervalued or overvalued?
See the intrinsic value estimate for Propanc Biopharma Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
PPCB looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with PPCB’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Propanc Biopharma Does
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The firm has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body.
- Headquarters
- Australia AU
- Employees
- 1
- IPO date
- Jun 15, 2012
Earnings Waterfall
Propanc Biopharma Inc
The intrinsic value for Propanc Biopharma Inc (PPCB) under the Base Case is hidden USD.
Compared with the current market price of 2.29 USD, the stock appears hidden.